Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | CNCHP | |||||||
GSE108476 |
The REMBRANDT study – a large collection of genomic data from brain cancer patients
|
2056 | Krithika Bhuvaneshwar | May 25, 2018 | ||||
GSE108475 |
The REMBRANDT study – a large collection of genomic data from brain cancer patients [SNP]
|
1506 | Krithika Bhuvaneshwar | May 25, 2018 | ||||
GSE25893 |
A comprehensive assessment of array-based platforms and calling algorithms for detection of copy number variants
|
385 | Stephen W Scherer | Jun 30, 2011 | ||||
GSE28030 |
Affymetrix SNP array data for Chronic Lymphocytic Leukemia_diagnostic sample_patient samples
|
369 |
|
Anders Isaksson | Apr 28, 2011 | |||
GSE31168 |
Genetic Landscape of Copy Number Alterations in Gastric Cancer
|
291 |
|
Niantao Deng | Feb 10, 2012 | |||
GSE72660 |
Integrated Analysis of Genome-Wide DNA Copy Number and Gene Expression with Patient Outcomes in Esophageal Adenocarcinoma [Copy Number]
|
276 | Tony Edward Godfrey | Nov 01, 2016 | ||||
GSE107513 |
The molecular basis of T-PLL is an actionable perturbation of TCL1/ATM- and epigenetically instructed damage responses
|
276 | Giuliano Crispatzu | Nov 30, 2017 | ||||
GSE30311 |
The histotype-specific copy-number landscape of ovarian cancer
|
200 |
|
Liang Goh | Oct 25, 2012 | |||
GSE66399 |
Prospective biomarker analysis of the randomized CHER-LOB study evaluating the dual anti-HER2 treatment with chemotherapy plus trastuzumab and lapatinib as neoadjuvant therapy for HER2-positive breast cancer
|
156 |
|
Enrico Tagliafico | Oct 06, 2015 | |||
GSE30481 |
A Map of Copy Number Variations in Chinese Populations
|
155 | Haiyi Lou | Dec 31, 2011 | ||||
GSE56311 |
Integrative profiling of follicular lymphoma at diagnosis and relapse
|
123 |
|
Michael R Green | Mar 02, 2015 | |||
GSE160982 |
SNP array of 121 AML patients at diagnosis
|
121 | Giorgia Simonetti | Jan 19, 2021 | ||||
GSE107507 |
The molecular basis of T-PLL is an actionable perturbation of TCL1/ATM- and epigenetically instructed damage responses [human SNP array]
|
113 |
|
Giuliano Crispatzu | Nov 30, 2017 | |||
GSE52901 |
Impact of Gene Dosage on Gene Expression, Biological Processes and Survival in Cervical Cancer: a Genome-Wide Follow-Up Study [Mapping250K; copy number]
|
112 |
|
INGRID MEDINA MARTINEZ | Jun 04, 2015 | |||
GSE132453 |
Comorbidities - microcephaly, facial dysmorphia and epilepsy - increase the risk of the pathogenic CNV finding in patients with intellectual disability and autism
|
112 | Zuzana Čapková | Jun 11, 2019 | ||||
GSE80460 |
SNP arrays in matched colorectal cancer and normal colonic mucosa.
|
97 |
|
Daniele F Condorelli | Aug 31, 2018 | |||
GSE43934 |
Whole Genome Characterization of Circulating Tumor Cells Identifies Novel Prognostic Genomic Alterations in Melanoma Metastasis
|
88 | Neal Percy Kawas | Jul 01, 2014 | ||||
GSE31339 |
Affymetrix SNP array data for Monoclonal Gammopathies samples
|
84 |
|
Maria Eugenia Sarasquete | Apr 01, 2012 | |||
GSE67460 |
Affymetrix SNP array data for chronic myelomonocytic leukemia samples
|
82 | Laura Palomo | Dec 01, 2015 | ||||
GSE35656 |
Affymetrix SNP array data for myelodysplastic syndrome with 5q deletion treated with lenalidomide
|
81 | Mar Mallo | Jul 01, 2013 |